Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 4:27 pm Purchase | 2024-10-31 | 13G | EYEPOINT INC EYPT | TCG Crossover GP II, LLC | 3,572,335 5.200% | 3,572,335![]() (New Position) | Filing History |
| 2024-11-06 08:54 am Purchase | 2024-10-31 | 13G | EYEPOINT INC EYPT | Federated Hermes, Inc. FHI | 3,707,364 5.440% | 3,707,364![]() (New Position) | Filing History |
| 2024-11-04 11:57 am Purchase | 2024-09-30 | 13G | EYEPOINT INC EYPT | VANGUARD GROUP INC | 3,048,182 5.690% | 3,048,182![]() (New Position) | Filing History |
| 2024-10-31 12:51 pm Sale | 2024-09-30 | 13G | EYEPOINT INC EYPT | FRANKLIN RESOURCES INC BEN | 4,012,048 7.500% | -628,603![]() (-13.55%) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | EYEPOINT INC EYPT | BlackRock Inc. BLK | 4,155,158 7.800% | 4,155,158![]() (New Position) | Filing History |
| 2024-05-01 5:08 pm Unchanged | 2024-04-30 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 5,156,299 9.900% | 0 (Unchanged) | Filing History |
| 2024-04-30 8:53 pm Purchase | 2024-04-30 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 5,156,299 10.350% | 5,156,299![]() (New Position) | Filing History |
| 2024-02-14 9:08 pm Sale | 2023-12-31 | 13G | EYEPOINT INC EYPT | RA Capital Management, L.P. | 3,095,136 6.100% | -313,570![]() (-9.20%) | Filing History |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | T. Rowe Price Associates, Inc. | 2,522,704 5.600% | 2,522,704![]() (New Position) | Filing History |
| 2024-02-13 12:00 pm Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | Suvretta Capital Management, LLC | 4,774,389 9.990% | 1,363,179![]() (+39.96%) | Filing History |
| 2024-02-07 07:54 am Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,466,420 9.150% | 2,516,420![]() (+129.05%) | Filing History |
| 2024-02-06 10:55 am Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | FRANKLIN RESOURCES INC BEN | 4,640,651 9.500% | 510,514![]() (+12.36%) | Filing History |
| 2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EYEPOINT INC EYPT | Cormorant Asset Management, LP | 6,038,235 12.360% | 6,038,235![]() (New Position) | Filing History |
| 2023-12-08 5:28 pm Sale | 2023-12-04 | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners, L.P. | 2,337,786 5.000% | -1,312,606![]() (-35.96%) | Filing History |
| 2023-09-11 11:15 am Sale | 2023-08-31 | 13G | EYEPOINT INC EYPT | FRANKLIN RESOURCES INC BEN | 4,130,137 11.800% | -1,644,372![]() (-28.48%) | Filing History |
| 2023-08-30 5:22 pm Sale | 2019-03-28 | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners, L.P. | 3,650,392 10.400% | -540,004![]() (-12.89%) | Filing History |
| 2023-05-01 4:23 pm Purchase | 2023-04-21 | 13G | EYEPOINT INC EYPT | Cormorant Global Healthcare Master Fund LP | 3,200,000 9.330% | 3,200,000![]() (New Position) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | EYEPOINT INC EYPT | RA Capital Management, L.P. | 3,408,706 9.990% | 1,801,847![]() (+112.13%) | Filing History |
| 2023-02-13 10:23 am Sale | 2022-12-31 | 13G | EYEPOINT INC EYPT | Suvretta Capital Management, LLC | 3,411,210 9.990% | -70,899![]() (-2.04%) | Filing History |
| 2023-01-31 11:44 am Sale | 2022-12-31 | 13G | EYEPOINT INC EYPT | FRANKLIN RESOURCES INC BEN | 5,774,509 16.900% | -2,558,967![]() (-30.71%) | Filing History |

